Response to Letter to the Editor From Rosenfield et al: “Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome”-Reference-Cited by-同舟云学术

Response to Letter to the Editor From Rosenfield et al: “Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome”

Published:2024-05-29 Issue: Volume: Page:
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Teede Helena¹^ORCID,Tay Chau T¹,Azziz Ricardo²

Affiliation:

1. Monash Centre of Health Research and Implementation, Monash University , Melbourne 3168 , Australia

2. Women and Infants Center, University of Alabama , Birmingham, AL 35233 , USA

Funder

Australian National Health

Medical Research Council

Publisher

The Endocrine Society

Link

https://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgae370/58233180/dgae370.pdf

Reference8 articles.

1. Letter to the editor on recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome;Rosenfield;J Clin Endocrinol Metab,2024

2. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome*;Teede;J Clin Endocrinol Metab,2023

3. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome;Teede;Fertil Steril,2018

4. Clinical assessment of body hair growth in women;Ferriman;J Clin Endocrinol Metab,1961

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rehabilitation of patients after surgical treatment for polycystic ovary syndrome;Rehabilitology;2024-09-06

2. The place of metformin in the treatment of carbohydrate metabolism disorders and insulin resistance during, before and after pregnancy: resolution of the expert council;Diabetes mellitus;2024-06-25

3. Consideration of Use of Semaglutide and Tirzepatide Prior to Pregnancy;Canadian Women's Health Today;2024-06-25

4. Rehabilitation of patients after surgical treatment of polycystic ovary syndrome;Vrach;2024-05-31

5. Research Advance on the Prevention and Treatment of Polycystic Ovary Syndrome Based on Dysbiosis of Gut Microbiota;Advances in Clinical Medicine;2024